| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Hcw Biologics Inc. (HCWB) have been net buyers, picking up 643,046 shares worth roughly $510K on balance. In the past 30 days, 2 insiders bought and 0 sold. Purchases have clustered in the most recent filings.
Leading the buying is Wong Hing C (Chief Executive Officer), now holding an estimated $325K in HCWB. Purchases at the executive level are worth more attention than sales, since sales can be prompted by tax or liquidity needs rather than a view on the stock.
HCWB sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 203.4K | $545.2K | - | |
| CEO | 125.8K | $337.3K | +23.2K | |
| CFO | 57.2K | $153.4K | - | |
| VP | 8.7K | $23.3K | +7.7K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 24, 2023 | Byam Rebecca | Chief Financial Officer | Buy | 58,486 | $1.56 | $91,082.08 | +5.1% | +22.3% | -31.0% | |
| Sep 14, 2022 | Byam Rebecca | Chief Financial Officer | Buy | 15,000 | $2.58 | $38,650.50 | +4.8% | -22.9% | -14.8% | |
| Sep 13, 2022 | Byam Rebecca | Chief Financial Officer | Buy | 30,000 | $2.61 | $78,414.00 | +5.2% | -16.3% | -21.4% | |
| Sep 9, 2022 | Wong Hing C | Chief Executive Officer | Buy | 10,000 | $2.69 | $26,880.00 | - | -24.6% | -25.2% | |
| Sep 7, 2022 | Wong Hing C | Chief Executive Officer | Buy | 10,000 | $2.57 | $25,680.00 | - | -21.2% | -24.7% | |
| Aug 31, 2022 | Byam Rebecca | Chief Financial Officer | Buy | 17,200 | $2.55 | $43,913.28 | +3.2% | -16.2% | -29.5% | |
| Aug 29, 2022 | Byam Rebecca | Chief Financial Officer | Buy | 20,000 | $2.55 | $51,020.00 | +4.0% | -14.4% | -24.0% | |
| Aug 25, 2022 | Byam Rebecca | Chief Financial Officer | Buy | 90,300 | $2.54 | $229,747.08 | +25.0% | -15.9% | -22.7% | |
| Jun 14, 2022 | Byam Rebecca | Chief Financial Officer | Buy | 66,452 | $2.42 | $160,798.46 | +35.8% | -2.2% | -21.9% | |
| Jun 10, 2022 | Wong Hing C | Chief Executive Officer | Buy | 1,520 | $2.19 | $3,325.76 | - | +23.7% | -6.0% |